Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

TMEM150B Activators

Chemical activators of transmembrane protein 150B can engage in distinct biochemical signaling pathways that lead to the functional activation of the protein. Forskolin is a diterpene that serves as an activator of adenylate cyclase, which catalyzes the conversion of ATP to cAMP. This increase in intracellular cAMP levels can activate transmembrane protein 150B through cAMP-dependent mechanisms. Similarly, IBMX, a non-selective phosphodiesterase (PDE) inhibitor, raises cAMP and cGMP levels, which in turn can activate transmembrane protein 150B by enhancing the signaling through these secondary messengers. Additionally, various PDE inhibitors such as Sildenafil, Vardenafil, and Tadalafil specifically target PDE5, augmenting cGMP levels within cells. The elevation of cGMP can trigger the activation of transmembrane protein 150B through cGMP-dependent protein kinases. Cilostazol and Anagrelide, both PDE3 inhibitors, also elevate cAMP levels that can lead to the activation of transmembrane protein 150B via cAMP-dependent signaling pathways.

In the same vein, Papaverine, a non-specific PDE inhibitor, boosts both cAMP and cGMP concentrations, which can activate transmembrane protein 150B through either cAMP or cGMP-dependent routes. Rolipram, by selectively inhibiting PDE4, leads to an accumulation of cAMP, which can then activate transmembrane protein 150B through pathways regulated by cAMP. Vinpocetine and Zaprinast, inhibitors of PDE1 and PDE5 respectively, result in the enhancement of both cAMP and cGMP levels, which can activate transmembrane protein 150B through a variety of signal transduction pathways. Lastly, Milrinone, another selective PDE3 inhibitor, increases cAMP concentration, thereby enabling the activation of transmembrane protein 150B through cAMP-linked signaling networks. Each chemical, through its unique action on different PDEs, contributes to the regulation of intracellular messenger levels, thereby influencing the activity of transmembrane protein 150B through direct interactions with the cAMP or cGMP signaling pathways that are integral to cellular responses.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Directly activates adenylate cyclase leading to increased cAMP levels which can activate transmembrane protein 150B by cAMP-dependent pathways.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Non-selective inhibitor of phosphodiesterases which increases levels of cAMP and cGMP, possibly leading to the activation of transmembrane protein 150B via secondary messengers.

Cilostazol

73963-72-1sc-201182
sc-201182A
10 mg
50 mg
$107.00
$316.00
3
(1)

Inhibits phosphodiesterase type 3 (PDE3) increasing cAMP levels which can activate transmembrane protein 150B through cAMP-mediated signaling pathways.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$516.00
$720.00
$16326.00
7
(1)

Inhibits PDE5, leading to increased cGMP levels which can activate transmembrane protein 150B through cGMP-dependent signaling mechanisms.

Tadalafil

171596-29-5sc-208412
50 mg
$176.00
13
(2)

Inhibits PDE5, increasing cGMP concentration which can activate transmembrane protein 150B via cGMP-dependent protein kinases.

Anagrelide

68475-42-3sc-491875
25 mg
$147.00
(0)

Inhibits PDE3, resulting in elevated cAMP levels which can activate transmembrane protein 150B through cAMP-dependent pathways.

Papaverine

58-74-2sc-279951
sc-279951A
sc-279951B
10 mg
50 mg
100 mg
$153.00
$265.00
$459.00
(0)

Non-selective PDE inhibitor, increases cAMP and cGMP levels, which can activate transmembrane protein 150B via cAMP or cGMP-dependent pathways.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Selective PDE4 inhibitor, increases cAMP levels which can activate transmembrane protein 150B through cAMP-regulated signaling pathways.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

Inhibits PDE1, leading to increased cAMP and cGMP levels which can activate transmembrane protein 150B through multiple signaling pathways.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$103.00
$245.00
8
(2)

Inhibits PDE5, increasing cGMP levels which can activate transmembrane protein 150B through cGMP-dependent signaling pathways.